Bank of New York Mellon Corp
BankPosition in ANIP — Ani Pharmaceuticals Inc
CIK 1390777
NEW YORK, NY
Position in ANIP
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$9,817,457
+$1,281,484 QoQ
Shares Held
118,597
+6.8% QoQ
Ownership
0.516%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 305 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. ANIP ranks #18 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in ANIP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,817,457 | 118,597 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $8,535,973 | 111,001 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $8,892,113 | 112,644 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $10,650,512 | 116,272 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $7,751,307 | 118,794 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $7,984,585 | 119,262 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $6,845,430 | 123,832 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $7,125,072 | 119,428 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,352,011 | 131,156 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $8,177,455 | 118,291 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $6,955,965 | 126,151 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $7,183,007 | 123,717 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $6,108,788 | 113,483 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $4,348,902 | 109,489 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $4,590,121 | 114,097 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,877,175 | 120,634 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,595,528 | 121,184 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,459,945 | 123,086 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $6,514,742 | 141,379 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,147,502 | 95,902 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $3,289,441 | 93,850 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,645,765 | 100,879 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,012,491 | 103,736 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,079,430 | 109,161 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,412,483 | 105,519 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,264,213 | 104,669 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||